YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHKR8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,227
Award facts
- Contract value 100% obligated
- $2,227.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1-dose vials. This firm fixed-price delivery order, awarded on November 26, 2025, with an ultimate completion date of December 18, 2025, contains no set-aside designation, indicating the award was made through unrestricted federal procurement. The order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy established to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has held a single-award IDC under the PPV-G GEN V program since November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, positioning the company as a regional prime vendor contractor. The company's product portfolio encompasses branded and generic pharmaceuticals, biologics, vaccines, and medical consumables, with this particular delivery order for YF-VAX (yellow fever vaccine) supporting routine military medical supply requirements. The contract structure enables DLA to issue multiple firm fixed-price delivery orders throughout the contract period to meet the diverse pharmaceutical needs of Department of Defense military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FHKR8?
SPE2DR26FHKR8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FHKR8 worth?
The government has obligated $2,227 on SPE2DR26FHKR8.
Is contract SPE2DR26FHKR8 an order under another contract?
Yes. SPE2DR26FHKR8 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKR8 competed?
The extent of competition for SPE2DR26FHKR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award